XTX Topco’s Astria Therapeutics ATXS Stock Holding History

XTX Topco’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35,936	Closed	-$470K	–	3833
2025 Q4	$470K	Buy	+35,936	New	+$429K	0.01%	1662
2025 Q3	–	Sell	-36,249	Closed	-$194K	–	2546
2025 Q2	$194K	Buy	+36,249	New	+$176K	0.01%	1717
2024 Q1	–	Sell	-28,716	Closed	-$221K	–	1832
2023 Q4	$221K	Buy	+28,716	New	+$159K	0.05%	885

XTX Topco's ATXS Position: Q1 2026 in Review

XTX Topco sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 35,936 shares — an estimated $470K sold.

XTX Topco first reported a position in ATXS in Q4 2023 and held it in 3 quarters. The position peaked at $470K in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

XTX Topco reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
XTX Topco sold 35,936 Astria Therapeutics shares in Q1 2026, an estimated $470K.
XTX Topco first reported a position in Astria Therapeutics in Q4 2023 and held it in 3 quarters.
XTX Topco's Astria Therapeutics position peaked at $470K in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.